VIDEO + ARTICLE: Scientists are applying an FDA-approved technique, Deep Brain Stimulation, to treat mild Alzheimer’s for 150 patients in Phase-3 clinical trials. Learn more.
In a first-of-its-kind study, FDA-Approved Dantrolene, a muscle relaxant, was delivered through the nose to Alzheimer’s lab animals. It eased their Alzheimer’s by providing therapeutic
VIDEO + ARTICLE: An experimental drug produced by Annovis has received its generic name following successful completion of its Phase II trials. Buntanetap is intended
MEDICATION: THE WORLD’S MOST POPULAR DEMENTIA-DRUG IS DONEPEZIL. Donepezil (Brand-name: Aricept®) boosts memory & thinking in Alzheimer’s. More donepezil means more boost – along with
PROGRESS IN THE NEWS – VIDEO & ARTICLE: In the lab, Alzheimer’s was delayed by FDA-approved “Dabigatran” (Pradaxa®), commonly used to clear blood clots. Can
DRUG NEWS: Genentech will showcase the breadth and promise of their Neuroscience Portfolio at the 2019 American Academy of Neurology Annual Meeting. It includes new
MEDICATION VIDEO + ARTICLE: Scientists found drug developed for diabetes “significantly reversed memory loss” in Alzheimer’s mice, through a triple method of action. See why
CLINICAL TRIALS: Find out why researchers think spraying nasal insulin through the nose can improve cognition, memory and daily function in people with Alzheimer’s. Learn
CLINICAL TRIAL NEWS – VIDEO + ARTICLE: Skeptical Alzheimer’s experts expressed surprising optimism regarding Biogen’s BAN-2401 drug. Dr. Ronald Peterson is one of the world’s
TIME MAGAZINE VIDEO: See Peter Wooding and his wife battle Alzheimer’s, 18 months into the Aducanamab Clinical Trial. On FDA’s Fast-Track program, the new vaccine’s
The “glymphatic system” removes brain waste. It may be a powerful new target to treat Alzheimer’s. Learn why scientists believe Alzheimer’s may arise when the system is not doing its cleaning properly.
Plaques are the best-known Alzheimer’s culprit. Cambridge scientists have figured out the 7 steps to forming these plaques. Find out how targeting the formation of these “oligomers” may hold the key to a cure.
UCLA researchers found active people build 5% more gray matter in their brain. See how this prevents Alzheimer’s.
Scientists say the neurons responsible for transforming experiences into memories are always the first to go in Alzheimer’s. Now they’re taking a closer look to try to figure out why, and what to do about it.
A research study finds when young healthy men had a full, uninterrupted night of rest, their blood levels showed a reduced level of tau, the biomarker for Alzheimer’s disease. The level was higher when they lost just one night of sleep. Learn more.
Here’s a good activity caregivers can use easily, contributed by one of our readers. It’s a simple game, great in mid-stage Alzheimer’s.
Meet Marley, a THERAPAWS therapy dog, helping the elderly that suffer from dementia. See pet therapy at work.
No spam, only news and updates.
